Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer

Objectives: To verify the importance of DNA ploidy on clinical outcome in endometrial carcinoma and to investigate whether the prognostic information obtained by this variable is independent from other clinical-pathologic features.

Materials and methods: Univariate and multivariate analysis of clinical and pathologic prognostic factors obtained from 203 consecutive cases of endometrial cancer, that had been surgically treated in our hospital, were performed.

Results: Significant prognostic factors according to the Kaplan-Meier method were age at the time of diagnosis, grade of differentiation, peritoneal cytology, node involvement, vascular invasion, myometrial infiltration and ploidy. At multivariate analysis only DNA ploidy resulted to be an independent variable.

Conclusions: In our analysis DNA content is the only parameter which preserved prognostic significance in multivariate analysis.

Endometrial cancer; Prognostic factors; Ploidy

[1] Genest P., Drouin P., Gerig L., Girard A., Stewart D., Prefontain M.: "Prognostic factors in early carcinoma of the endometrium" Am. J. Clin. Oneal., 1987, 10 (1), 71.

[2] Morrow C. P., Bundy B. N., Kurman R. J.: "Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium". Gynecol. Oneal., 1991, 40, 55.

[3] Petterson F.: "Annual report on the results of treatment rn gynecological cancer. Radimhemmet, Stockholm". Int. J. G)．necol Ohstet., 1991, 36 (suppl.), 132.

[4] Silverman M. B., Roche P. C., Kho R. M., Keeney G. L., Li H., Podratz K. C.: "Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma". Gynecol. Oneal., 2000, 77 (1), 1.

[5] Maggi R.,C agnazzo G.,A tlante G., Marinaccio M.: "Risk groups and adjuvant therapy in surgical staged endometrial cancer patients. A randomized multicenter study comparing chemotherapy with radiation therapy". Int. J. Gynecol. Cancer, 1999, 9, 85.

[6] Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A.: "Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry". J Histochem. Cytochem, 1983, 31, 1333.

[7] Shankey T. V., Rabinovitch P. S., Bagwell B., Bauer K. D., Duque R. E., Hedley D. W. et al.: "Guidelines for implementation of clinical DNA cytometry". Cytometry, 1993, 14, 472.

[8] Joensun H., Klemi P. J.: "DNA aneuploidy in adenomas of endocrine organs". Am. J. Pathol., 1988, 132, 145.

[9] Kaplan E. I., Meier P.: "Nonparametric estimation from mcomplete observation". J. Am. Stat. Assoc., 1958, 53, 457.

[10] Cox D. R.: "Regression models and life tables". J. Res. Stat. Soc., 1972, 34, 187.

[11] Creasman W. T., Morrow P. C., Bundy B. N. et al.: "Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncologic Group study". Cancer, 1987, 60, 2035.

[12] Mangioni C., De Palo G., Marubini E.,Del Vecchio M.: "Surgical pathologic staging in apparent stage I endometrial carcinoma" Gynecol. Cancer, 1993, 3, 373.

[13] Lindhal B., Raustam J., Willen R.: "Five year survival rate in endometrial carcinoma stage I-II: Influence of degree of tumor differentiation, age, myometrial invasion and DNA content". British J. Obstet. Gynecol., 1994, 101, 621.

[14] Susini T, Rapi S., Savino L, Baddi V., Berti P., Massi G.: "Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters “ Am. J. Obstet. Gynecol., 1994, 170, 527.

[15] Abel er V. M., Kjorstad K. E.: "Endometrial adenocarcinoma rn Norway". Cancer, 1991, 67, 3093.

[16] Maneschi M., Maneschi F, Geraci P. et al.: "Surgical pathological staging of endometrial carcinoma and results of treatment". Eur. J Gynecol. Oncol., 1992, 13 (suppl. I), 30.

[17] Wolfson A.H., Sightler S. E., Marko! AM. et al.: "The prognostic significance of surgical staging for carcinoma of the endometrium". Gynecol. Oncol., 1992, 45, 142.

[18] Takeshima N.,H irai Y., Tanaka N. et al.: "Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion". Obstet. & Gynecol., 1996, 88, 2, 280.

[19] Ikeda M., Watanebe Y., Nanjoh T, Noda K.: "Evaluation of DNA ploidy in endometrial cancer". Gynecol. Oncol., 1993, 50, 25.

[20] Susini T, Rapi S., Massi D., Savino L, Amunni G., Taddei G. L, Massi G.: "Preoperative evaluation of tumor ploidy in endometrial carcinoma. An accurate tool to identify patients at risk for extrauterine disease and recurrence". Cancer, 1999, 86 (6), 1005.

[21] Rodenburg C. J.,C ornelisse C. J., Heintz P. A.,H erinans J., Fleuren G. J.:'Tumor ploidy as a major prognostic factor in advanced ovarian cancer". Cancer, 1987, 59, 317.

[22] Friedlander M. L,H edley D. W., SwansonC ., Russel P.: "Prediction of long term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer". J. Clin. Oncol., 1988, 6, 282.

[23] Kallioniemi 0., Punnonen R., Mattila J., Lehtinen M., Koivula T.: "Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer". Cancer, 1988, 61, 334.

[24] Iversen 0., Laerum 0.: "Ploidy disturbances in endometrial and ovarian carcinomas. A review". Anal. Quant. Cytol. Histol., 1985, 7, 327,

[25] Atkin N.B.: "Prognostic significance of ploidy level in human tumors.C arcinoma of the uterus". 1. N. C. J.,1976, 56, 909.

[26] Moberger B., Auer G., Forfslund G.: "The prognostic significance of DNA measurement in endometrial carcinoma". Cytometry, 1985, 5, 430.

[27] Iversen 0.: "Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma". Am. J. Obstet. Gynecol., 1986, 155, 770.

[28] Lindahl B., Alm P., Killander D., Langstrom E., Trope C.: "Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations". Anticancer Res., 1987, 7, 781.

[29] Lindahl B., Alm P., Ferno M. et al.: "Prognostic value of flow cytometric DNA measurements in stage I-II endometrial carcinoma: Correlations with steroid receptor concentrations, tumor myometrial invasion, and degree of differentiation". Anticancer Res., 1987, 7, 791

[30] Britton LC., Wilson T 0., Gaffey T A. et al.: "Flow cytometric DNA analysis of stage I endometrial carcinoma". Gynecol. Oncol., 1989, 34, 317.

[31] Newbury R., Schuerch C., Goodspeed N., Fanning J., Glidewell O., Evans M.: "DNA content as a prognostic factor in endometrial carcinoma". Obstet. & Gynecol., 1990, 76, 2, 251.

[32] Melchiorri C.,C hieco P., Lisignoli G., Marabini A.: "Ploidy disturbances as an early indicator of intrinsic malignancy in endometrial carcinoma". Cancer, 1993, 72, 1. 165.

[33] Mariani A., Sebo T J., Katzmann J. A., Keeney G. L, Roche P C., Lesnick T J., Podratz K. C.: "Pretreatment assessment of prognostic indicators in endometrial cancer". Am. 1. Obstet. Gynecol., 2000, 182, 6, 1535,